Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 13, 2025 • 5:30 AM ET

Date/Time Source News Release
06/12/2025 08:01 AM EDT Business Wire AI-Designed GLP-1 Peptides from ImmunoPrecise Antibodies Surpass Semaglutide in Receptor Activation Studies
06/05/2025 08:01 AM EDT Business Wire ImmunoPrecise Announces AI-Driven Breakthrough in Universal Dengue Vaccine Discovery
05/21/2025 08:49 AM EDT Business Wire ImmunoPrecise Antibodies Engages CORE IR to Enhance Investor Engagement Efforts
05/20/2025 08:28 AM EDT Business Wire ImmunoPrecise Antibodies (IPA) to Present at Maxim Group's 2025 Virtual Tech Conference
05/12/2025 08:01 AM EDT Business Wire IPA's LENSai(TM) Platform Delivers X-Ray-Level Epitope Mapping Insights in Hours, Matching Gold-Standard Methods with Greater Speed
04/11/2025 08:40 AM EDT Business Wire ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai(TM) with FDA's Shift to Non-Animal Testing Methods
03/28/2025 08:01 AM EDT Business Wire ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025
03/13/2025 07:02 AM EDT Business Wire ImmunoPrecise Antibodies and a Global Biotechnology Leader Enter into a USD $8M-$10M Partnership for the Development of Novel Cancer Therapeutics.
03/11/2025 10:17 PM EDT Business Wire IPA to Reschedule Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 28, 2025
03/05/2025 08:01 AM EST Business Wire IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 13, 2025
Page

Additional News

As of June 13, 2025 • 5:30 AM ET

Date/Time Source News Release
04/03/2025 12:00 PM EDT Zacks ImmunoPrecise Antibodies (IPA) Upgraded to Buy: What Does It Mean for the Stock?
03/28/2025 12:59 PM EDT SeekingAlpha ImmunoPrecise Antibodies Ltd. (IPA) Q3 2025 Earnings Call Transcript
03/28/2025 09:15 AM EDT Zacks ImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Misses Revenue Estimates
03/28/2025 08:20 AM EDT SeekingAlpha ImmunoPrecise GAAP EPS of -C$0.66, revenue of C$6.22M
03/28/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Friday, March 28th, 2025
03/28/2025 05:30 AM EDT US Earnings Reports Expected earnings - ImmunoPrecise Antibodies Ltd.
03/27/2025 05:50 PM EDT Zacks P3 Health Partners Inc. (PIII) Reports Q4 Loss, Lags Revenue Estimates
03/26/2025 01:56 AM EDT SeekingAlpha BMW and Alibaba deepen strategic partnership to develop AI for cars in China
03/13/2025 09:13 AM EDT SeekingAlpha ImmunoPrecise in $8M deal with biotech firm for ADCs in cancer treatments
03/13/2025 07:15 AM EDT Zacks Nyxoah SA (NYXH) Reports Q4 Loss, Lags Revenue Estimates
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.